Navigation Links
GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands
Date:6/3/2009

TBWA assigned alli and Smoking Control

Grey assigned US brands TUMS, Citrucel and FiberChoice

PITTSBURGH, June 3 /PRNewswire-FirstCall/ -- GlaxoSmithKline Consumer Healthcare (GSK Consumer Healthcare) (NYSE: GSK) has announced advertising agency changes to support growth for global brands. The changes will see GSK Consumer Healthcare partnering with agencies that have comparable market presence to its brands, with a proven ability to roll out world class ideas.

TBWA, part of the Omnicom Group, is appointed GSK's global creative agency for the weight loss brand alli(R) and for the Smoking Control franchise, including Nicorette(R), NicoDerm(R) CQ and Commit(R) sold in the US. TBWA won these global assignments following a rigorous appointment process facilitated by Agency Assessments International. The global creative agency accounts were previously held by Arnold, New York.

Grey currently manages the accounts for a number of GSK's global brands -- Aquafresh(R), Sensodyne(R), Denture Care (Polident(R), Poligrip(R) and Corega(R)) and Breathe Right(R). They have also been awarded TUMS(R), Citrucel(R) and FiberChoice(R) in the US. The agency account for TUMS and Citrucel was previously held by Arnold, New York. The agency account for FiberChoice was previously held by Nelson Henry.

Commenting on the agency assignments, Peter Kirkby, Vice President, Global Marketing Excellence, GSK Consumer Healthcare, said: "GSK Consumer Healthcare has an industry-leading, balanced brand presence in both the world's developed and fastest-growing markets. Our global brands are fundamental to future growth strategy and we want to partner with world class communications agencies with a solid global footprint that can help us drive growth.

"We were enormously impressed by TBWA's passion and performance throughout the pitch process. TBWA won their assignments based on the strength of their strategic thinking and their ability to drive big, brand-driven, creative ideas across the world's most dynamic and fast-growing markets.

"Our association with Grey is reaching new heights. Recent work on Aquafresh, Sensodyne, Denture Care and Breathe Right has been enormously successful. I am very pleased to see these additional brands assigned to their highly capable teams."

About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R), NicoDerm(R) CQ and Commit(R) as well as many medicine cabinet staples, including Abreva(R), Aquafresh(R), Sensodyne(R), TUMS(R) and Breathe Right(R).

About GlaxoSmithKline

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.gsk.com.


'/>"/>
SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
11. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... “The Saint ... Saint with Trin, and Omega Station” is the creation of published author, Chris Jackson. ... Dallas Metroplex where he works in the Dallas Independent School District teaching English. He ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, a pre-clinical stage ... the treatment of Acute Ischemic Stroke (AIS), today announced it has appointed Creganna ... advances towards regulatory and clinical phases. , "This is another important step for ...
(Date:4/22/2017)... ... April 22, 2017 , ... Ecommerce sales have grown every year since ... $394.9 billion. The consequences of rapid innovation and growth are often neglected in ... it is every business and individual’s job to give something back to the planet ...
(Date:4/22/2017)... ... ... San Juan Capistrano summer camp team at the Boys and Girls Club of ... to provide physical activities for all campers. To read the report, click here ... increase in specialty camps that focus on what the report terms as “sitting subjects” like ...
(Date:4/21/2017)... Boston, MA (PRWEB) , ... April 21, 2017 ... ... Boston University professor Christopher Salas-Wright finds that youth violence is declining—and at noteworthy ... in the relative proportion of young people involved in violence in the United ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... , April 18, 2017 Research and ... Market 2017-2021" report to their offering. ... The global arthroscopy devices market to grow at a ... report, Global Arthroscopy Devices Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:4/18/2017)... SUNNYVALE, Calif. , April 18, 2017 /PRNewswire/ ... results of collaboration started in 2016, in which ... "Artificial Brain SOINN". The companies achieved initial results ... ultrasound solution by Artificial Brain SOINN. The results ... Tokyo Big Sight, April 19-21, at booths 4505 ...
(Date:4/18/2017)... , April 18, 2017 Recursion ... biological science with machine learning techniques to discover treatments ... Dr. Yolanda Chong as vice president of ... Johnson & Johnson in Belgium , ... that focused on applying high-dimensional biological approaches to the ...
Breaking Medicine Technology: